Foster Corp. recently announced that it has become the North America distributor for Repsol‘s healthcare polyolefins portfolio.
The company will distribute Repsol’s polypropylene, polyethylene and ethylele-vinyl acetate copolymers within the North American healthcare markets.
Repsol’s medical-grade polyolefins are typically used in a number of healthcare applications like syringe barrels and medical bags. The company offers 27 grades of polyolefins that includes polypropylene homopolymers and copolymers, low density and high density polyethylene and EVA copolymers with vinyl acetate content ranging from 7.5% to 28%. The medical-grade polymers are USP ClassVI and ISO 10993 compliant.
“Polyolefins are used in more medical devices and packaging than any other thermoplastic. Today, these economical polymers are being evaluated for a wider range of applications than ever before,” said Larry Johnson, executive VP of Foster Corporation. “To support medical device development from prototype through production, we offer Repsol polypropylene, polyethylene and EVA copolymer medical grades in 25 kg (55 lb) through truckload quantities.”
